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A b s t r a c t .  Magentic Resonance Imaging with laser-polarized 129Xe can be uti- 
lized to trace blood flow and perfusion in tissue for a variety of biomedical ap- 
plications. Polarized xenon gas intoduced in to the lungs dissolves in the blood 
and is transported to organs such as the brain where it accumulates in the tissue. 
Spectroscopic studies combined with imaging have been used to produce brain 
images of 129Xe in the rat head. This work establishes that nuclear polarization 
produced in the gas phases survives transport to the brain where it may be im- 
aged. Increases in polarization and delivered volume of 129Xe will allow clinical 
measurements of regional blood flow. 
I I N T R O D U C T I O N  
Advances in laser polarization of 3He and 129Xe, motivated in large part by 
polarized target experiments, has led to significant activity in NMR and MRI 
of laser-polarized noble gases for medical applications. This is because the 
NMR signal per atom for laser polarized gases is sufficient to make up for the 
small concentrations compared to protons in tissue used in conventional NMR 
and MRI. Gas phase images of 3He or 129Xe have been obtained from excised 
mouse lungs [11, in vivo guinea pig lungs [2], and humans [3-5]. Gas phase 
imaging may provide detailed, tomographic information about lung ventilation 
as dicussed in other contributions in this session. With xenon, it is possible to 
create tissue phase images in addition to gas phase images. Xenon dissolves 
in blood [6], accumulates in the brain [7], and may be treated as a freely 
diffusible tracer in vivo [8]. These properties have allowed xenon to be used 
by SPECT [9] and CT [10] to measure regional cerebral blood flow (rCBF) by 
analyzing uptake and washout curves of xenon in the brain [11]. A number 
of spectroscopic studies have also been performed of 129Xe dissolved in blood 
in vitro [12,13] and in blood and/or tissue in vivo [14]. Given high levels of 
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nuclear polarization and desirable biological properties for measuring rCBF, 
we set out to determine the feasibility of using laser-polarized 129Xe as a 
magnetic tracer to measure rCBF and perfusion in other tissue such as the 
heart. For this method to be successful, the nuclear polarization created in 
the gas phase must survive transport from the lungs, into the blood, through 
the heart, and into the brain. 
II TECHNIQUES 
We have constructed an optical pumping and polarized ngXe delivery sys- 
tem shown in figure 1. 
Figure 1. Schematic diagram of laser polarization and delivery system for 
129Xe MRI. The optical pumping takes place in the fringing field of the 2 T 
MRI magnet. The n9Xe is polarized in the pumping chamber, transfered to 
a storage volume and delivered to the animal in single breath doses. 
High nuclear polarization of noble gases is achieved by spin-exchange with 
optically-pumped Rb [15-19]. The results shown below were obtained with 
129Xe polarized to approximately 3.5% in an optical pumping cell containing 
1700 Torr of xenon (26.4% 129Xe) and 200 Torr of N2 to quench radiation 
trapping. The optical pumping cell, a 75 cc Pyrex cylinder with hemispheri- 
cal end windows, is coated with octadecyltriehlorosilane to reduce depolarizing 
129Xe-wall interactions [20]. High vacuum techniques are essential to minimize 
contaminants such as paramagnetie 02 which decrease nuclear spin T1 and 
limit absolute polarization [21]. Two Teflon valves mounted on the cell allow 
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evacuation, filling, and delivery of the gases. Optimum density of rubidium 
vapor was achieved by heating the cell to 95~ Two laser diode arrays (Op- 
topower, Tucson, AZ), each providing at 15 Watts of continuous laser light, 
were used for optical pumping. Commercial availability of these high pow- 
ered, efficient, GaA1As laser diode arrays at the Rb D1 wavelength has made 
a tremendous impact on the field [22]. The entire apparatus including lasers, 
optics, valves, heating and cooling, and transport tubing lies in the periph- 
eral magnetic field of the 2 T solenoid magnet with the optical pumping cell 
collinear with the solenoid axis. Typical polarization times in these studies 
were 10 to 15 minutes, producing sufficient amounts of polarized 12~Xe to 
ventilate a 250 gm rat for 40 to 50 seconds. NMR and MRI data were ob- 
tained with a three-turn, doubly-tuned proton-129Xe surface coil [23] with 3.5 
cm diameter. Excitation and response of the surface coil were determined by 
phantom studies to be sufficiently homogenous over the region of interest. 
Spectra and images obtained with rats are shown in figures 2 and 3. The 
129Xe spectrum shown in figure 2 was obtained with 64 averages and a 50 
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Figure 2. Magnetic resonance spectra of 129Xe obtained with the head coil. 
The blood tissue resonance is near 200 ppm. The small gas peak near 0 ppm 
is due to gas in the intubation tube, sinuses, and mouth. 
The 129Xe tissue image shown in Fig. 3 was acquired with a 2D chemical shift 
imaging pulse sequence that uses phase encoding to separate the blood/tissue 
spectral component from the gas phase peak [24] The sequence produced a 
slice thickness of 10 ram, a field-of-view of 50 mm x 50 ram, a block size of 256 
complex points and an estimated flip angle of 20 ~ . The total imaging time was 
73 s. The 256 x 16 x 16 CSI dataset was zero filled along both phase-encode 
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dimensions to produce a final matrix size of 256 x 32 x 32. These data were 
Fourier transformed along each dimension with the magnitude of the spectrum 
calculated in each voxel. A Lorentzian function was fitted to the 129Xe tissue 
phase resonance in each of the 1024 spectra and the amplitudes of the fit used 
to generate the 129Xe image shown in Fig. 2A. The proton image shown in 
Fig. 2C was acquired with a conventional spin-echo pulse sequence with a slice 
thickness of 10 mm, a field of view of 50 x 50 mm. Precise registration of the 
129Xe image with respect to the proton image is important to interpretation 
of information contained in the 129Xe image. 
Figure 3. Magnetic resonance images of the rat head with 
A) legXe and B) proton imaging. 
III R E S U L T S  A N D  D I S C U S S I O N  
The NMR spectrum acquired from the rat head (figure 2) has two resolvable 
resonances: a small gas resonance due to 129Xe in the intubation tube and a 
single, dominant, blood/tissue resonance at 194.5 ppm relative to the gas 
peak. The NMR image of 129Xe in the head is presented in figure 3A. The 
gray scale for indicates signal amplitude relative to the RMS noise fluctuations 
of the background (SNR). The maximum SNR for a voxel is approximately 
20. The blood/tissue resonance seen in Fig. 2 is assigned to 129Xe in brain 
tissue based on the following argument: the rat brain cerebral blood volume is 
relatively low ( ~ 5%); cerebral blood flow very high ( ~ 1.0 ml/g per min.); 
and the partition coefficient between brain and blood is approximately 1.0 [7]. 
Since brain tissue has a much larger capacity for xenon than the brain blood 
and since xenon will freely diffuse into brain tissue, the NMR signal observed 
will be dominated by 129Xe in the brain. This reasoning is supported by the 
image of 129Xe in the rat head (Figs. 2A and B) which shows that the 129Xe 
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signal is localized to the brMn and not seen the surrounding fat or muscle. 
129Xe magnetization observed in the rat brain is not uniform. 129Xe signal in 
the cerebellum is less than the signal in the cerebrum. The signal difference 
could be due to partial volume effects or to lower blood flow in the cerebellum 
than in the cerebrum. Sakurada et al. found blood flow for cerebellar gray 
matter similar to or somewhat lower than that of cerebral gray matter [?]. 
In addition, inhalation of xenon has been shown to increase cerebral but not 
cerebellar regional blood flow [28]. Figures 3A and B also show that the two 
hemispheres of the cerebrum are marginally separated in the 129Xe image. 
The time dependence of 129Xe magnetizatio in the brain has been studied 
with a model of 129Xe magnetization uptake in the brain [25,26]. The data and 
results are shown in figure 4, where time dependence from the model are shown 
for several values of 129Xe TI. We use this to estimate the T1 relaxation time 
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Figure 4. Uptake of blood/tissue spectral component in the head. The solid 
lines are model results for several T1 129Xe relaxation times. 
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I V  C O N C L U S I O N  
The work described here is part of the large world-wide effort to use laser 
polarized noble gases for biomedical NMR and MRI. This effort has engaged 
many physicists with expertise in polarized targetry. Our work represents 
the first use of laser-polarized 129Xe for NMR spectroscopy and imaging of 
the brain, in vivo. The importance of laser-polarized 129Xe in studies of re- 
gional brain activation by measurement of rCBF follows from the limitations 
of currently employed techniques and the complementary use of radioactive 
and magnetic tracers. 
In order to extend these techniques to humans, greater volumes and polar- 
izations of laser-polarized 129Xe will be required. In our current apparatus, we 
accumulate and store laser-polarized 129Xe by freezing [29] for long-duration 
animal and human rCBF experiments. We also mix oxygen and reduce the 
Xe concentration to approximately 30% to avoid anoxia and anesthetic effects 
of xenon. Signal loss must be compensated for by increases in polarization, or 
the use of expensive isotopically enriched 129Xe. 
Though useful experiments can be performed with 129Xe polarization of 1 
- 10%, higher polarization will be necessary t o  increase the spatial and/or 
temporal resoulution of 129Xe brain imaging. Polarizations of 50% or more 
have been achieved in small volumes with more suitable lasers. Advances in 
laser technology and the polarization delivery system should yield significantly 
higher 129Xe polarization in the future. 
Laser-polarized 129Xe imaging need not be limited to the brain. Since xenon 
dissolves in blood and tissue, combined gas phase/tissue phase pulmonary 
imaging of 129Xe may provide tomographic ventilation/perfusion information 
not available with 3He. In addition, measurement of cardiac perfusion may be 
feasible with laser-polarized 129Xe if the blood and tissue components resonate 
at different frequencies. Finally, since the polarization produced by laser opti- 
cal pumping is magnetic field independent, it is interesting to consider of MRI 
at low fields (0.1 T or less). Low field techniques may provide less expensive, 
lighter, and more compact scanners for medical purposes. 
V A C K N O W L E D G M E N T  
We gratefully acknowledge essential discussions with Drs. Paul Carson, Kirk 
Frey, Robert Koeppe, and Martin Prince and Philip Sherman for assistance 
with animal care and use. This work was supported in part by NSF and 
the University of Michigan's Office of Vice President for Research, Frontiers 
in Neuroscience Fund, the Department of Physics, and the Department of 
Radiology. 
205 
R E F E R E N C E S  
1. M.S. Albert, G.D. Cates, B. Driehuys, W.Happer, B Saam, C.S. Springer, Jr., 
and A. Wishnia, Nature, 370, 199-201 (1994). 
2. R.D. Black, H.L. Middleton, G.D. Cates, G.P. Corer, B. Driehuys, W. Happer, 
L.W. Hedlund, G.A. Johnson, M.D. Shattuck, and J.C. Swartz, Radiology, 199, 
867-70 (1996). 
3. J.R. MacFall, H.C. Charles, R.D. Black, H. Middleton, J.C. Swartz, B. Saara, 
B. Driehuys, C. Erickson, W. Happer, G.D. Cates, G.A. Johnson, and C.E. 
Ravin. Radiology, 200, 553-8 (1996). 
4. H.U. Kauczor, D. Hofmann, K.F. Kreitner, H~ Nilgens, R. Surkau, W. Hell, A. 
Potthast, M.V. Knopp, E.W. Otten, M. Thelen, Radiology, 201,564-8 (1996). 
5. J.P. Mugler, III, B. Driehuys, J.R.Brookeman, G.D. Cates, S.S. Berr, R.G. 
Bryant, T.M. Daniel, E.E. de Lange, C.J~ Erickson, W. Happer, D.P. Hinton, 
T. Maier, B.T. Saam, K.L. Sauer, M.E. Wagshul, Proc., ISMRM, 5th Annual 
Meeting, Vancouver,2113 (1997). 
6. S.Y. Yeh, R.E. Peterson,. Appl. Physiol, 20, 1041-7 (1965). 
7. R.Y.Z. Chen, F.C. Fan, S. Kim, K.M. Jan, S. Usami, S. Chien, J. Appl. Phys- 
iol., 49, 178-181 (1980). 
8. S.S. Kety, Pharmacol. Rev., 3, 1-41 (1951). 
9. N.A. Lassen, in "Cerebral Metabolism and Neural Function" (J.V. Passon- 
neau, R.A.Hawkins, W.D. Lust, F.A. Welsh, Eds.) pp. 144-150, Williams and 
Wilkins, Baltimore, (1980). 
10. K. Nambu, R. Suzuki, K. Hirakawa. Radiology, 195, 53-57 (1995). 
11. S.S. Kety, C.F. Schmidt, Am. J. Physiol., 143, 53 (1945). 
12. A. Bifone, Y.Q. Song, R. Seydoux, R.E. Taylor, B.M. Goodson, T. Pietrass, 
T.F. Budinger, G. Navon, A. Pines,Proc. Natl. Acad. Sci., 93, 12932-6, (1996). 
13. M. Albert, V.D. Schepkin, T.F. Budinger, J. Comput. Assist. Tomogr., 19, 975- 
978 (1995). 
14. M.E. Wagshul, T.M. Button, H.F. Li Z. Liang, C.S. Springer, K. Zhong, and 
A. Wishnia, Magn. Reson. Med., 36, 183- 91 (1996). 
15. T. G. Walker, W. Happer, Rev. Mod. Phys., 69, 629 - 42 (1997). 
16. T.E. Chupp, K.P. Coulter, Phys. Rev. Left., 55, 1074-1077 (1985). 
17. X. Zeng, Z. Wu, T. Call, E. Miron, D. Schreiber, W. Happer, Phys. Rev. A, 
31, 260- 78 (1985). 
18. T.E. Chupp, M. Wagshul, K.P. Coulter, A.B. McDonald, W. Happer,Phys. 
Rev. C, 36, 2244-2241 (1987). 
19. G.D. Cates, R.J. Fitzgerald, A.S. Barton, P. Bogorad, M. Gatzke, N.R. New- 
bury, B. Saam, Phys Rev. A, 45~ 4631-9 (1992). 
20. E.R. Oteiza, Ph.D. Dissertation, Harvard University (1992). 
21. B. Sa~m, W. Happer, H. Middleton, Phys. Rev. A, 52, 862-865 (1995). 
22. M.E. Wagshul, T.E. Chupp, Phys. Rev. A, 40, 4447-4454 (1989). 
23. V. Cross, R. Hester, J. Waugh, Rev. Sci. lnstrum., 47, 1486-1488 (1976). 
24. T.R. Brown, B.M. Kincaid, K. Ugurbil, Proc. Natl. Adac. Sci. U.S.A., 79, 
3523-3526 (1982). 
206 
25. S. Peled et al. Mag. Res. Med. 37, 809-815 (1997). 
26. K.P. Coulter et al. private communication - to be published (1997). 
27. O. Sakurada, C. Kennedy, J. Jehle, J.D. Brown, G.L. Carbin, L. Sokoloff, Am. 
J. Physiol., 234, H59-H66 (1978). 
28. L. Junck, V. Dhawan, H.T. Thaler, D.A. Rottenberg, J. Cereb. Blood Flow 
Metab., 5, 126-132 (1985). 
29. G.D. Cates, D.R. Benton, M. Gatzke, W. Happer, K.C. Hasson, N.R. Newbury, 
Phys. Rev. Lett., 65, 2591-2594 (1990). 
207 
